| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 01/08/2003 | CN1390253A High order nucleic acid based structures |
| 01/08/2003 | CN1390222A Imidazole compounds used as phosphodiesterase VII inhibitors |
| 01/08/2003 | CN1390220A Kinase inhibitors as therapeutic agents |
| 01/08/2003 | CN1390219A Pyrazolopyrimidines as therapeutic agents |
| 01/08/2003 | CN1390215A 酪氨酸激酶抑制剂 Tyrosine kinase inhibitor |
| 01/08/2003 | CN1390207A [5-chloro-6-phenyl-2-(4-trifluoromethylphenyl)-4-pyrimidinyl amino] acetamide derivatives, process for producing the same, medicinal compositions the same and intermediate of these compounds |
| 01/08/2003 | CN1390137A A Blocking monoclonal antibody to VLA-1 and its use for the treatment of inflammatory disorders |
| 01/08/2003 | CN1390130A Glucosamine and egg for reducing inflammation |
| 01/08/2003 | CN1390128A Use of adatanserin for treating neurogenerative disorders |
| 01/08/2003 | CN1390125A High lipid diet |
| 01/08/2003 | CN1390122A Tissue factor antagonists and methods of use thereof |
| 01/08/2003 | CN1389458A P-methylsulfonyl phenylacrylate derivative and its prepn process and anti-inflammatory effect |
| 01/08/2003 | CN1389262A Externally applied medicine for stopping itching, relieving pain and eliminating swelling |
| 01/08/2003 | CN1389260A Medicated bag for flexibilizing tendons, setting fracture and relieving pain and its prepn. process |
| 01/08/2003 | CN1389255A Composite Chinese medicine for treating rheumarthritis and rheumatoid arthritis |
| 01/08/2003 | CN1389247A Medicine prepared with cactus and taraxacum and its prepn. process |
| 01/08/2003 | CN1389246A Medicine tablet for eliminating bone pain and its prepn. |
| 01/08/2003 | CN1389215A Hongbing ointment as one kind of locally administrated prepn. |
| 01/08/2003 | CN1389214A Compound liniment for treating autoimmune disease |
| 01/08/2003 | CN1389209A Myocarditis treating medicine |
| 01/08/2003 | CN1098264C Substituted 4-(1H-benzimidzol-2-yl-amino) piepridines useful for the treatment of allergic diseases |
| 01/08/2003 | CN1098256C Substd. benzenesulfonamide derivatives as prodrugs of COX-2 inhibitors |
| 01/08/2003 | CN1098255C Novel substituted piperazine derivatives having tachyknin receptor antagonists activity |
| 01/08/2003 | CN1098102C Medicine for treating rheumatism and its preparing process |
| 01/08/2003 | CN1098092C Capsule for treating rhematism |
| 01/08/2003 | CN1098083C Artificial tiger-bone and its producing process and use |
| 01/08/2003 | CN1098071C Transdermal device for delivery of flurbiprofen |
| 01/08/2003 | CN1098070C Guanylhydrazones for treating inflammatory conditions |
| 01/08/2003 | CN1098069C Transdermal device for delivery of flurbiprofen |
| 01/07/2003 | US6504028 Process for preparing benzoxazin-4-one polymer conjugates |
| 01/07/2003 | US6504005 Long-acting drugs and pharmaceutical compositions comprising them |
| 01/07/2003 | US6503934 Substituted thiadiazolesulfonamides |
| 01/07/2003 | US6503931 Use of 4-amino pyridine for treatment of peripheral neuropathies |
| 01/07/2003 | US6503930 Pyrazole derivatives as p38 kinase inhibitors |
| 01/07/2003 | US6503926 Nitrogen heterocycle compounds |
| 01/07/2003 | US6503910 Hydroxamic and carboxylic acid derivatives |
| 01/07/2003 | US6503905 3,3-biarylpiperidine and 2,2-biarylmorpholine derivatives |
| 01/07/2003 | US6503713 Methods for identifying RNA binding compounds |
| 01/07/2003 | US6503543 Tryptophan source from plants and uses therefor |
| 01/07/2003 | US6503542 Herbal compositions for treating immunological disorders |
| 01/07/2003 | US6503539 Matrix protein compositions for wound healing |
| 01/07/2003 | CA2076307C Orally-active elastase inhibitors |
| 01/07/2003 | CA2075684C 1-acylpiperidine compounds |
| 01/06/2003 | CA2392187A1 Combination preparation for the therapy of immunological diseases |
| 01/05/2003 | CA2392189A1 Heterocyclo-alkylsulfonyl pyrazoles as anti-inflammatory/analgesic agents |
| 01/05/2003 | CA2390181A1 Sulfonyl aryl triazoles as anti-inflammatory/analgesic agents |
| 01/03/2003 | WO2003000896A2 POLYNUCLEOTIDES AND POLYPEPTIDES OF THE IFNα-5 GENE |
| 01/03/2003 | WO2003000886A1 Novel g protein-coupled receptor protein and dna thereof |
| 01/03/2003 | WO2003000864A2 Nucleic acid-associated proteins |
| 01/03/2003 | WO2003000859A2 G-protein coupled receptors |
| 01/03/2003 | WO2003000846A2 A novel g protein-coupled receptor, gave 3 |
| 01/03/2003 | WO2003000844A2 Protein modification and maintenance molecules |
| 01/03/2003 | WO2003000709A2 Sialic acid derivatives for use as siglec inhibitors |
| 01/03/2003 | WO2003000699A1 Substituted 1-oxa-2,8-diaza-spiro[4,5]dec-2-ene derivatives as medicaments for the treatment of pain |
| 01/03/2003 | WO2003000697A1 Furoisoquinoline derivative, process for producing the same, and use |
| 01/03/2003 | WO2003000696A1 COMBINATION THERAPY OF AN SODm AND A CORTICOSTEROID FOR PREVENTION AND/OR TREATMENT OF INFLAMMATORY DISEASE |
| 01/03/2003 | WO2003000695A1 Pyrrolopyrimidines as protein kinase inhibitors |
| 01/03/2003 | WO2003000694A1 6-phenyldihydropyrrolopyrimidinedione derivatives |
| 01/03/2003 | WO2003000691A1 Carboline derivatives as pdev inhibitors |
| 01/03/2003 | WO2003000688A1 Azaindoles |
| 01/03/2003 | WO2003000687A1 Tyrosine kinase inhibitors |
| 01/03/2003 | WO2003000684A1 Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor type-1 (pai-1) |
| 01/03/2003 | WO2003000682A1 (pyrimidyl)(phenyl)substituted fused heteroaryl p38 inhibiting and pkg kinase inhibiting compounds |
| 01/03/2003 | WO2003000680A1 Diamine derivatives |
| 01/03/2003 | WO2003000668A1 Oxa(thia)zolidine compounds, process for preparation thereof and anti-inflammatory agents |
| 01/03/2003 | WO2003000657A1 Diamine derivatives |
| 01/03/2003 | WO2003000653A1 Substituted n-acyl aniline derivatives, production and use thereof as medicaments |
| 01/03/2003 | WO2003000323A1 Safety shield system for prefilled syringes |
| 01/03/2003 | WO2003000322A1 Safety shield system for prefilled syringes |
| 01/03/2003 | WO2003000310A2 Nasal devices |
| 01/03/2003 | WO2003000273A1 Modulating serum amyloid a interaction with tanis and agents useful for same |
| 01/03/2003 | WO2003000268A1 Use of na+ channel blockers and aspirin in manufacturing drugs for producing analgesia synergistically in mammals |
| 01/03/2003 | WO2003000264A1 Antihistamines for the treatment of nasal congestion and nasal obstruction |
| 01/03/2003 | WO2003000250A1 3-fluoro-pyrrolidines as antidiabetic agents |
| 01/03/2003 | WO2003000246A1 The use of rhein and derivatives thereof in pain treatment |
| 01/03/2003 | WO2003000244A1 Benzenesulfonyl(thio)ureas for the treatment of septic shock and sirs |
| 01/03/2003 | WO2003000243A1 Antimicrobial nanoemulsion compositions and methods |
| 01/03/2003 | WO2003000238A1 Pharmaceutical compositions of adsorbates of amorphous drug |
| 01/03/2003 | WO2003000195A2 Method and material for treating immune diseases |
| 01/03/2003 | WO2003000185A2 Complex mixtures exhibiting selective inhibition of cyclooxygenase-2 |
| 01/03/2003 | WO2003000183A2 Method of treating atherosclerosis and other inflammatory diseases |
| 01/03/2003 | WO2003000181A2 Dipeptidyl peptidase inhibitors for the treatment of diabetes |
| 01/03/2003 | WO2003000180A2 Dipeptidyl peptidase inhibitors for the treatment of diabetes |
| 01/03/2003 | WO2003000156A1 Zero-order prolonged release coaxial implants |
| 01/03/2003 | WO2003000014A2 Spherical protein particles and methods of making and using them |
| 01/03/2003 | WO2002087605A3 Modified fvii in treatment of ards |
| 01/03/2003 | WO2002087596A3 Use of azithromycin for the manufacture of a medicament for treatment of non-infective inflammatory diseases |
| 01/03/2003 | WO2002083667A3 Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases |
| 01/03/2003 | WO2002080914A3 Use of substituted imidazo[1,2-a]-pyridine compounds as medicaments |
| 01/03/2003 | WO2002072584A3 Tetrahydro-pyrazino (1,2-a) indoles for the treatment of central nervous disorders |
| 01/03/2003 | WO2002069960A3 Use of mek inhibitors for treating inflammation and virus induced hemorrhagic shock |
| 01/03/2003 | WO2002060869A3 Use of p38 inhibitors for the treatment of inflammation-enhanced cough |
| 01/03/2003 | WO2002047673A3 Methods and compositions to treat conditions associated with neovascularization |
| 01/03/2003 | WO2002046170A8 Anilinopyrimidine derivatives as jnk pathway inhibitors and compositions and methods related thereto |
| 01/03/2003 | WO2002045702A3 Tricyclic therapeutics for chemokine mediated diseases |
| 01/03/2003 | WO2002043653A3 Crystalline glucosamine sulphate metal salts |
| 01/03/2003 | WO2002012501A3 Anti-dual integrin antibodies, compositions, methods and uses |
| 01/03/2003 | WO2002010387A3 G-protein coupled receptors |
| 01/03/2003 | WO2002007759A3 Clostridial toxin derivatives and methods for treating pain |
| 01/03/2003 | WO2002004611A3 Aminoacyl trna synthetases |